JAZZ vs SWIM · P/E 1988, rev $2.28B vs P/E 78, rev $314.8M
Jazz Pharmaceuticals PLC (JAZZ) versus Latham Group Inc (SWIM) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latham Group Inc (SWIM) is a building products & equipment company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SWIM revenue for 2026-06-27 was $314.8M. Net income was $4.2M. SWIM currently screens at market cap $638.7M and trailing P/E 77.7.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SWIM currently screens at market cap $638.7M and trailing P/E 77.7.
Not investment advice. Open the JAZZ and SWIM stock pages for the full models.
Not investment advice.